The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma
Authors
Keywords
Cancer treatment, Melanomas, Melanoma cells, Mitochondria, Cell death, Antigens, Lysosomes, MTT assay
Journal
PLoS One
Volume 11, Issue 2, Pages e0148980
Publisher
Public Library of Science (PLoS)
Online
2016-02-17
DOI
10.1371/journal.pone.0148980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intratumoral immunotherapy for melanoma
- (2015) Manisha Singh et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study
- (2015) Riccardo Danielli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma
- (2015) Carmela Rozera et al. Journal of Translational Medicine
- In-situ tumor vaccination: Bringing the fight to the tumor
- (2015) Robert H Pierce et al. Human Vaccines & Immunotherapeutics
- Host defense peptides for treatment of colorectal carcinoma – a comparative in vitro and in vivo analysis
- (2015) Claudia Maletzki et al. Oncotarget
- Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315
- (2014) Ketil André Camilio et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mitochondrial damage-associated molecular patterns and vascular function
- (2014) C. F. Wenceslau et al. EUROPEAN HEART JOURNAL
- Therapeutic Implications of Immunogenic Cell Death in Human Cancer
- (2014) Fabio Palombo et al. Frontiers in Immunology
- LTX-315 (Oncopore™)
- (2014) Ketil André Camilio et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Cell-Death-Associated Molecular Patterns As Determinants of Cancer Immunogenicity
- (2013) Sylvain Ladoire et al. ANTIOXIDANTS & REDOX SIGNALING
- Killing cancer cells, twice with one shot
- (2013) M E Bianchi CELL DEATH AND DIFFERENTIATION
- Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
- (2013) H Inoue et al. CELL DEATH AND DIFFERENTIATION
- Immune modulation by multifaceted cationic host defense (antimicrobial) peptides
- (2013) Ashley L Hilchie et al. Nature Chemical Biology
- Many faces of DAMPs in cancer therapy
- (2013) O Krysko et al. Cell Death & Disease
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death
- (2012) Isabelle Martins et al. Autophagy
- Anticancer mechanisms of action of two small amphipathic β2,2-amino acid derivatives derived from antimicrobial peptides
- (2012) Dominik Ausbacher et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Chlamydia trachomatis hijacks intra-Golgi COG complex-dependent vesicle trafficking pathway
- (2012) I. D. Pokrovskaya et al. CELLULAR MICROBIOLOGY
- Anticancer activity of small amphipathic β2,2-amino acid derivatives
- (2012) Terkel Hansen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Role of Helicity on the Anticancer Mechanism of Action of Cationic-Helical Peptides
- (2012) Yi-Bing Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge
- (2012) J. R. Baird et al. JOURNAL OF IMMUNOLOGY
- Cancer and Innate Immune System Interactions
- (2012) Yanan Liu et al. JOURNAL OF IMMUNOTHERAPY
- Unknown
- (2012) Huan Yang et al. MOLECULAR MEDICINE
- ATP Release from Dying Autophagic Cells and Their Phagocytosis Are Crucial for Inflammasome Activation in Macrophages
- (2012) Gizem Ayna et al. PLoS One
- Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
- (2011) Oliver Kepp et al. CANCER AND METASTASIS REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Oncolytic Activities of Host Defense Peptides
- (2011) Sammy Al-Benna et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
- (2011) J. L. Guerriero et al. JOURNAL OF IMMUNOLOGY
- Studies on Mechanism of Action of Anticancer Peptides by Modulation of Hydrophobicity Within a Defined Structural Framework
- (2011) Y.-b. Huang et al. MOLECULAR CANCER THERAPEUTICS
- High-mobility group box 1 and cancer
- (2010) Daolin Tang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide
- (2010) Gerd Berge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
- (2010) L. Aymeric et al. CANCER RESEARCH
- DAMPs and inflammatory processes: the role of redox in the different outcomes
- (2009) Sonia Carta et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
- (2009) Michael R. Elliott et al. NATURE
- Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
- (2008) R. J. Prestwich et al. CLINICAL CANCER RESEARCH
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started